Cetera Investment Advisers’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Cetera Investment Advisers's HALO Position: Q2 2026 in Review
Cetera Investment Advisers increased its Halozyme (HALO) stake by 15% in Q2 2026, buying an estimated $561K and bringing the position to 62,087 shares worth $4.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1643.
Cetera Investment Advisers first reported a position in HALO in Q1 2024 and has held it in 10 quarters since. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Cetera Investment Advisers held 62,087 shares of Halozyme worth $4.86M as of Q2 2026.
- Cetera Investment Advisers bought 8,222 Halozyme shares in Q2 2026, an estimated $561K.
- Halozyme made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1643 holding.
- Cetera Investment Advisers first reported a position in Halozyme in Q1 2024 and has held it in 10 quarters since.
- 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.